Health Condition 1: null- Patients are the who have an ileostomy done previously and are now posted for ileostomy closure.
Conditions
Interventions
Intervention1: Transversus abdominis plane block under ultrasound guidance with 0.375% bupivacaine.: group A will have 35 number of patients who would receive 0.375% of ropivacaine 25ml (by two approa
Sponsors
Basavatarakam IndoAmerican Cancer Hospital and Research Institute
Eligibility
Inclusion criteria
Inclusion criteria: All patients under American Society of Anaesthesiologists physical status I and II will be included in the trial and will undergo randomization.
Exclusion criteria
Exclusion criteria: Exclusion criteria will include patients unable or unwilling to give informed consent, those with a history of relevant drug allergy, those currently using analgesics or who have current acute or chronic pain or are receiving medical therapies considered to result in tolerance to opioids, and patients with coagulopathies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare 24 hour morphine consumption in patients who undergo ileostomy closure with and without transversus abdominis plane block under ultrasound guidance.Timepoint: 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| TO compare visual analogue score at rest and movement, to compare nausea and vomiting postoperativelyTimepoint: 24 hours | — |
Countries
India
Contacts
Public ContactAbhijit Nair
Department of Anaesthesia, 4th floor
Outcome results
None listed